Investigational Site Number 826001

Manchester M20 4BX

0 studies enrolling now · 2 studies all time

What they study most

Sphingomyelin Lipidosis, Squamous Cell Lung Cancer

Studies at this site

• Safety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients <18 Years of Age With Acid Sphingomyelinase Deficiency — Completed
• Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) — Completed